Comparing as AI Academic & Research Search EnginesOpenEvidence vs Elicit
Core Differences
The fundamental difference lies in their primary purpose and target user base, which dictates their architectural focus and workflow integration:
- OpenEvidence is a clinical decision support (CDS) platform designed for practicing physicians at the point of care. Its architecture prioritizes real-time, highly accurate, and sourced-only answers from licensed medical literature to aid in patient diagnosis and treatment. The workflow is centered around immediate clinical queries and integration into existing electronic health record (EHR) systems.
- Elicit is an AI research assistant built for academic researchers conducting systematic literature reviews and evidence synthesis. Its workflow is structured around automating the laborious stages of research, such as paper screening, structured data extraction, and generating evidence reports from a large corpus of academic papers. It focuses on discovery, organization, and synthesis of research findings rather than direct clinical application.
Verdict by Category
Best for Clinical Practice
OpenEvidence provides real-time, peer-reviewed answers directly relevant to patient care, integrated into clinical workflows.
Best for Academic Research
Elicit automates the most time-consuming steps of systematic literature reviews, from screening to data synthesis.
Best Value (Free Tier)
Elicit offers a genuinely useful free plan with unlimited search, summaries, and full-text chat with papers for any researcher.
Best for Data Grounding & Safety
OpenEvidence grounds all answers exclusively in licensed peer-reviewed medical literature, ensuring zero hallucination risk for clinical use.
Best for Workflow Integration
OpenEvidence offers direct Epic EHR integration, embedding clinical AI support within existing physician workflows.
Best for AI Agent Capabilities
Elicit's Research Agent autonomously searches, screens, and synthesizes literature from a single research question.
Editor's Take
Honest opinion from our review team
As a reviewer, I found that using OpenEvidence felt like having an incredibly knowledgeable, lightning-fast medical consultant by my side. The sheer confidence that comes from knowing every answer is sourced from peer-reviewed literature is invaluable in a clinical setting. It's not just about getting an answer, but getting a trustworthy, actionable answer in seconds, which is a game-changer when time is critical. The seamless nature of querying via voice or through an EHR integration truly feels like the future of clinical support.
Elicit, on the other hand, felt like gaining a superpower for research. The experience of uploading a research question and watching the AI autonomously screen papers, extract specific data points into a structured table, and then synthesize findings was nothing short of revolutionary. It transformed what used to be weeks of meticulous, often tedious, work into hours. The ability to chat with individual papers and trace every extracted data point back to its source sentence instilled a deep sense of trust and transparency, which is paramount in academic rigor. While OpenEvidence brought speed to clinical decisions, Elicit brought efficiency and depth to the research process.
Detailed Comparison22 Criteria
Complete side-by-side breakdown of specifications, capabilities, and feature parity
Both OpenEvidence and Elicit operate on a freemium model, but their free tiers and value propositions differ significantly based on their target audience.
- OpenEvidence offers its core platform entirely free for all verified US healthcare professionals (NPI verification required). This is a phenomenal value proposition for individual clinicians, removing any cost barrier to accessing advanced AI clinical decision support. The free tier includes full medical AI search, DeepConsult, Visits, Voice Mode, and the AI-Integrated Doctor Dialer. The paid model shifts to enterprise-level deployments for health systems, encompassing EHR integrations, custom knowledge bases, and API licensing. This structure ensures widespread individual adoption while monetizing institutional value.
- Elicit provides a genuinely functional free Basic plan that is accessible to anyone without requiring a credit card. This free tier includes unlimited paper search, abstract summaries, and full-text chat with papers, making it highly valuable for students, independent researchers, or those with infrequent needs. The value here is in democratizing access to powerful research tools. For heavy users, Plus ($12/month) and Teams ($14/user/month) plans offer expanded usage of advanced features like the Research Agent, Research Reports, and figure extraction, along with collaborative workspaces for teams. Elicit's recent price reductions for higher tiers further enhance its value for dedicated researchers and institutions.
OpenEvidence Pros & Cons
Pros
- Free for all verified US physicians — no cost barrier for individual clinician adoption
- 757,000+ verified physicians, 40%+ of US doctors use it daily — most widely adopted clinical AI in the US
- $12B valuation (January 2026), $250M Series D — Thrive Capital and DST Global backed
- Answers grounded exclusively in peer-reviewed literature — zero hallucination risk from non-medical sources
- 20M+ clinical consultations per month — proven real-world clinical usage at unprecedented scale
- Epic EHR integration live at Sutter Health — first public health system embedding of clinical AI in EHR
- DeepConsult AI agent handles multi-step clinical reasoning — goes beyond basic search to structured clinical analysis
Cons
- Withdrew from EU and UK in April 2026 — US-only availability limits international use
- Free tier requires verified NPI number — not accessible to non-US clinicians or students without credentials
- Impact on actual clinical decision-making scored only 1.95/4 in one study — physicians still cautious
- DeepConsult and enterprise features require institutional pricing
- Full chart-aware clinical support (reading patient records proactively) not yet available
- Only 20% of physicians fully support AI in clinical decision-making — adoption barriers remain
Elicit Pros & Cons
Pros
- Purpose-built for systematic reviews — automates the most time-consuming steps (screening, extraction, synthesis)
- Structured data extraction with source traceability — every extracted data point links back to its source sentence
- 138M+ paper database with semantic matching — finds relevant papers based on meaning, not just keywords
- Free tier is genuinely useful — unlimited search, summaries, and full-text chat with no credit card required
- Research Agent autonomously searches and synthesizes literature from a single question
- Zotero integration lets researchers bring existing reference libraries into Elicit workflows
- Trusted by 2M+ researchers including at top academic and medical institutions globally
Cons
- Research Agent and Research Reports usage limited on free plan — heavy systematic review users need Plus or Teams
- Database of 138M papers is strong but not as large as Consensus AI (220M) or Google Scholar
- Less suited for discovering very recent preprints or non-indexed grey literature
- No built-in citation manager — relies on Zotero export for reference management
- Teams and Enterprise pricing is per-user and can add up for large research groups
AI Verdict
In the rapidly evolving landscape of AI-powered knowledge platforms, OpenEvidence and Elicit stand out as specialized tools, each addressing critical needs within distinct professional domains. OpenEvidence is America's leading AI clinical decision support platform, meticulously designed for verified US physicians. Its core strength lies in providing instant, AI-synthesized answers grounded exclusively in peer-reviewed medical literature from authoritative sources like NEJM and JAMA. This stringent adherence to verified content virtually eliminates the hallucination risk inherent in general LLMs, making it a trusted co-pilot for high-stakes clinical decision-making. OpenEvidence excels in real-time patient care scenarios, offering features like DeepConsult for multi-step clinical reasoning and Visits for AI support during encounters, and even boasts Epic EHR integration for seamless workflow embedding. It's built for speed, accuracy, and clinical relevance at the point of care, used by over 40% of US doctors daily for 20M+ consultations monthly.
Conversely, Elicit is an AI research assistant purpose-built for systematic literature review and evidence synthesis, catering to over 2 million researchers across various disciplines. While OpenEvidence focuses on applying existing, verified knowledge to patient cases, Elicit empowers researchers to discover, screen, extract, and synthesize new or existing knowledge from a vast database of 138M+ papers. Its key differentiators include automated title and abstract screening, structured data extraction with source traceability to the exact sentence, and a Research Agent that can autonomously search and synthesize literature from a research question. Elicit is ideal for academics, policy analysts, and anyone requiring rigorous, transparent, and scalable literature review processes. It significantly reduces the manual burden of systematic reviews, allowing researchers to focus on analysis and interpretation rather than tedious data collection. Both platforms leverage AI, but OpenEvidence optimizes for clinical application and safety, while Elicit optimizes for research methodology and discovery.
Frequently Asked Questions
QHow does OpenEvidence ensure the accuracy and safety of its clinical answers?
OpenEvidence exclusively grounds its AI-synthesized answers in licensed, peer-reviewed medical literature from leading publishers like NEJM, JAMA, and Cochrane. This strict sourcing policy, along with human expert review, is designed to eliminate the hallucination risk associated with general AI models, ensuring clinical relevance and safety for verified US physicians.
QCan Elicit be used for research outside of medicine, such as in social sciences or computer science?
Yes, Elicit is designed as a general AI research assistant for systematic literature review and evidence synthesis across various disciplines. While it's popular in medicine, its core functionalities like automated screening, structured data extraction, and research report generation are highly applicable to social sciences, computer science, policy research, and any field requiring rigorous literature review.
QWhat is the primary difference between OpenEvidence and a general AI chatbot like ChatGPT for medical queries?
The critical difference is 'grounding.' OpenEvidence answers exclusively from licensed, peer-reviewed medical literature, providing traceable citations and eliminating hallucination, making it safe for clinical use. General AI chatbots like ChatGPT are trained on vast, uncurated internet data, lack specific medical grounding, and are prone to generating plausible but incorrect or fabricated information, making them unsuitable and unsafe for clinical decision support.
QDoes Elicit integrate with reference managers like Zotero or EndNote?
Elicit offers direct integration with Zotero, allowing researchers to import their existing reference libraries into Elicit workflows for screening and analysis. While it doesn't have native integration with EndNote, users can often export from EndNote into a compatible format (e.g., RIS) and then import into Elicit if needed.
QIs OpenEvidence available to healthcare professionals outside the US?
Currently, OpenEvidence is available exclusively to verified US healthcare professionals. The platform withdrew from the EU and UK in April 2026, and access requires NPI verification for individual clinicians.
Popular Comparisons
Direct feature matrices, pricing breakdowns, and real-world benchmark duels





